{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:44:16Z","timestamp":1793083456317,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jconrel.2022.01.027","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T10:52:59Z","timestamp":1642848779000},"page":"207-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"special_numbering":"C","title":["Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles"],"prefix":"10.1016","volume":"343","author":[{"given":"Martijn J.W.","family":"Evers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangbing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander A.A.","family":"Kooijmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan","family":"Vink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mies","family":"van Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Vader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia C.A.","family":"de Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine A.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Mastrobattista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P.G.","family":"Sluijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Schiffelers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2017","key":"10.1016\/j.jconrel.2022.01.027_bb0005","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature10147","article-title":"Heart regeneration","volume":"473","author":"Laflamme","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0015","article-title":"Cellular and molecular mechanism of cardiac regeneration: a comparison of newts","volume":"10","author":"de Wit","year":"2020","journal-title":"Zebrafish Mammals Biomol."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.10.003","article-title":"Repairing the heart: state-of the art delivery strategies for biological therapeutics","volume":"160","author":"Yang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0025","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.115.303632","article-title":"Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model","volume":"115","author":"Lin","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0030","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1073\/pnas.1116136109","article-title":"YAP1, the nuclear target of hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy","volume":"109","author":"von Gise","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrm3619","article-title":"Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair","volume":"14","author":"Xin","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2009.04.060","article-title":"Neuregulin1\/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury","volume":"138","author":"Bersell","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0045","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/ncb3149","article-title":"ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation","volume":"17","author":"D\u2019Uva","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0050","first-page":"H1791","article-title":"Vascular endothelial growth factor administration in chronic myocardial ischemia","volume":"270","author":"Harada","year":"1996","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0055","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1161\/01.CIR.0000105723.91637.1C","article-title":"Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia","volume":"108","author":"House","year":"2003","journal-title":"circulation"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0060","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/hc0802.104407","article-title":"Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial","volume":"105","author":"Simons","year":"2002","journal-title":"circulation"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2017.11.010","article-title":"Direct in vivo reprogramming with Sendai virus vectors improves cardiac function after myocardial infarction","volume":"22","author":"Miyamoto","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"7400","key":"10.1016\/j.jconrel.2022.01.027_bb0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors[J]","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0080","series-title":"Pharmacokinetics and half-life of protein therapeutics, Therapeutic proteins: strategies to modulate their plasma half-lives","volume":"48","author":"Meibohm","year":"2012"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0085","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Kariko","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0090","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0095","series-title":"RNA Therapeutics","first-page":"237","article-title":"Messenger RNA as a novel therapeutic approach","author":"Stanton","year":"2017"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0100","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nbt.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.omtn.2018.08.021","article-title":"Ablation of a single N-glycosylation site in human FSTL 1 induces cardiomyocyte proliferation and cardiac regeneration","volume":"13","author":"Magadum","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0110","first-page":"184","article-title":"Intramyocardial stem cell injection: go(ne) with the flow","volume":"38","author":"van den Akker","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.910155","article-title":"Liposome accumulation in regions of experimental myocardial infarction","volume":"198","author":"Caride","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2016.12.042","article-title":"Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction","volume":"247","author":"Allijn","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0125","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1002\/ange.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"124","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0130","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0135","first-page":"E3351","article-title":"Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles","volume":"115","author":"Arteta","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/nat.2018.0734","article-title":"MicroRNAs enable mRNA therapeutics to selectively program cancer cells to self-destruct","volume":"28","author":"Jain","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0145","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.pharmtox.45.120403.095802","article-title":"The cardiac fibroblast: therapeutic target in myocardial remodeling and failure","volume":"45","author":"Brown","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0150","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/eurjhf\/hfs066","article-title":"A contemporary view on endothelial function in heart failure","volume":"14","author":"Shantsila","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02938356","article-title":"Role of inflammation in the progression of heart failure","volume":"9","author":"Yndestad","year":"2007","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0160","doi-asserted-by":"crossref","first-page":"22720","DOI":"10.1039\/C8NR07755J","article-title":"Dissociation of fluorescently labeled lipids from liposomes in biological environments challenges the interpretation of uptake studies","volume":"10","author":"M\u00fcnter","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0165","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1007\/s11095-012-0818-1","article-title":"Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method?","volume":"29","author":"Liu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0170","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1021\/acsnano.8b02881","article-title":"Quantitative assessment of nanoparticle biodistribution by fluorescence imaging, revisited","volume":"12","author":"Meng","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.11.020","article-title":"Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles","volume":"222","author":"Kwekkeboom","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0185","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1073\/pnas.1620874114","article-title":"Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics","volume":"114","author":"Dahlman","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0190","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.omtm.2018.04.003","article-title":"Biocompatible, purified VEGF-A mRNA improves cardiac function after intracardiac injection 1 week post-myocardial infarction in swine","volume":"9","author":"Carlsson","year":"2018","journal-title":"Mol. Ther. Meth. Clin. Dev."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0195","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900424","article-title":"aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model","volume":"3","author":"Chen","year":"2020","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0200","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.119.041882","article-title":"Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction","volume":"141","author":"Hadas","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0205","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1021\/mp5006239","article-title":"Synthetic chemically modified mrna-based delivery of cytoprotective factor promotes early cardiomyocyte survival post-acute myocardial infarction","volume":"12","author":"Huang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0210","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.119.043067","article-title":"Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration","volume":"141","author":"Magadum","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0215","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.omtm.2020.03.019","article-title":"Optimization of 5\u2032 untranslated region of modified mRNA for use in cardiac or hepatic ischemic injury","volume":"17","author":"Sultana","year":"2020","journal-title":"Mol. Ther. Meth. Clin. Dev."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0220","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ymthe.2017.03.016","article-title":"Optimizing cardiac delivery of modified mRNA","volume":"25","author":"Sultana","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/mt.2015.193","article-title":"Myocardial delivery of lipidoid nanoparticle carrying modRNA induces rapid and transient expression","volume":"24","author":"Turnbull","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0230","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3389\/fphys.2020.00590","article-title":"Loss of miR-132\/212 has no Long-term beneficial effect on cardiac function after permanent coronary occlusion in mice","volume":"11","author":"Lei","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0235","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ejhf.1406","article-title":"Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the heart failure association (HFA) of the European Society of Cardiology","volume":"21","author":"de Boer","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cvr\/cvv223","article-title":"In vivo cardiac reprogramming using an optimal single polycistronic construct","volume":"108","author":"Ma","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jconrel.2022.01.027_bb0245","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.01.027_bb0250","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ymthe.2018.11.018","article-title":"mRNA-based protein replacement therapy for the heart","volume":"27","author":"Magadum","year":"2019","journal-title":"Mol. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:17:40Z","timestamp":1759162660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":50,"alternative-id":["S0168365922000414"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.027","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}